Carlsmed, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CARL Nasdaq 3840 carlsmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Carlsmed, Inc.

CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Dec 9th, 2025 5:28 am
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Dec 3rd, 2025 5:00 am
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - Nov 6th, 2025 2:01 pm
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - Oct 23rd, 2025 2:01 pm
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary - Sep 29th, 2025 7:00 am
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index - Sep 22nd, 2025 7:00 am
Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks - Sep 12th, 2025 4:02 am
UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results - Aug 28th, 2025 4:09 pm
Carlsmed® Reports Second Quarter 2025 Financial Results - Aug 28th, 2025 2:01 pm
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage - Aug 18th, 2025 12:25 pm
CVS Health upgraded, Occidental downgraded: Wall Street's top analyst calls - Aug 18th, 2025 7:33 am
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - Aug 14th, 2025 7:05 am
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Aug 1st, 2025 7:05 am
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Jul 28th, 2025 7:05 am
Carlsmed Announces Pricing of Initial Public Offering - Jul 22nd, 2025 6:03 pm
Carlsmed Announces Launch of Initial Public Offering - Jul 22nd, 2025 5:20 pm